Sci Rep 13, 20998 (2023)
Quality, purity, and dose consistency may therefore vary between manufacturers and batches, and consumers should purchase from reputable, established suppliers
Reported side effects in human anecdotal use are generally mild and may include: Mild nausea, particularly with oral administration Redness, itching, or irritation at the injection site Temporary dizziness or mild headache Changes in appetite or weight A significant theoretical concern revolves around its pro-angiogenic properties
For example, if the provider injects bupivacaine into the knee joint for pain management using CT guidance, the proper coding is 20610, 77012
Participants were randomized to receive placebo or one of several retatrutide dose levels (1 mg, 4 mg, 8 mg, or 12 mg) administered subcutaneously once weekly for 48 weeks